Ernst‐Ulrich Griese

2.1k citations

29 papers · 1.6k indexed · h-index 19

Pharmacology top 0.2%
Oncology top 5%
Physiology top 5%
Molecular Biology
Pediatrics, Perinatology and Child Health top 5%

Co-authors: Michel Eichelbaum Matthias Schwab Ulrich Klotz Ulrike Friedrich Péter Fritz Ulrich M. Zanger Gerd Mikus Klaus‐Peter Thon
Topics: Pharmacogenetics and Drug Metabolism (15 papers)Drug Transport and Resistance Mechanisms (4 papers)Telomeres, Telomerase, and Senescence (4 papers)
Cited by: Pharmacology Aging Oncology
Journals: Proceedings of the National Academy of Sciences The Lancet International Journal of Pharmaceutics
Partner nations: Germany United States Australia

In The Last Decade

Ernst‐Ulrich Griese

29 papers receiving 1.6k citations

Peers

Countries citing papers authored by Ernst‐Ulrich Griese

Since Specialization

Citations

This map shows the geographic impact of Ernst‐Ulrich Griese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernst‐Ulrich Griese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernst‐Ulrich Griese more than expected).

Fields of papers citing papers by Ernst‐Ulrich Griese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernst‐Ulrich Griese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernst‐Ulrich Griese. The network helps show where Ernst‐Ulrich Griese may publish in the future.

Co-authorship network of co-authors of Ernst‐Ulrich Griese

This figure shows the co-authorship network connecting the top 25 collaborators of Ernst‐Ulrich Griese. A scholar is included among the top collaborators of Ernst‐Ulrich Griese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernst‐Ulrich Griese. Ernst‐Ulrich Griese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2′-O-methyl-RNA 2011 ·International Journal of Pharmaceutics ·Meng Dong,(unknown),Brigitta Loretz,Noha Nafee,Ulrich F. Schaefer,Godehard Friedel,Susanne Ammon-Treiber,Ernst‐Ulrich Griese,Claus‐Michael Lehr,Ulrich Klotz,Thomas E. Mürdter	25
2	Nanoparticle mediated delivery of 2′-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells 2009 ·Lung Cancer ·Julia Beisner,Meng Dong,Sebastian Taetz,Noha Nafee,Ernst‐Ulrich Griese,Ulrich F. Schaefer,Claus‐Michael Lehr,Ulrich Klotz,Thomas E. Mürdter	17
3	Differential expression and function of CYP2C isoforms in human intestine and liver 2003 ·Pharmacogenetics ·(unknown),Oliver von Richter,Martin F. Fromm,Tanja Richter,Klaus Peter Thon,Hermann Wisser,Ernst‐Ulrich Griese,Michel Eichelbaum,Kari T Kivist	106
4	Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism 2002 ·Pharmacogenetics ·(unknown),Matthias Schwab,Ernst‐Ulrich Griese,Claudia Marx,B. Müller‐Oerlinghausen,P. S. Schönhöfer,Christoph Meisner,Christoph H. Gleiter,Michel Eichelbaum,Klaus Mörike	13
5	Cytochrome P450 2D6 Deficiency and its Clinical Relevance in a Patient Treated with Risperidone 2002 ·Pharmacopsychiatry ·Michael D. Köhnke,Ernst‐Ulrich Griese,(unknown),I. Gaertner,G Barth	26
6	Diclofenac does not interact with codeine metabolism in vivo: A study in healthy volunteers 2002 ·PubMed ·Susanne Ammon,Claudia Marx,Christoph Behrens,Ute Hofmann,Thomas E. Mürdter,Ernst‐Ulrich Griese,Gerd Mikus	17
7	Telomeres in Neonates: New Insights in Fetal Hematopoiesis 2001 ·Pediatric Research ·Ulrike Friedrich,Matthias Schwab,Ernst‐Ulrich Griese,Péter Fritz,Ulrich Klotz	70
8	Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in Aborigines from Western Australia 2001 ·Pharmacogenetics ·Ernst‐Ulrich Griese,Kenneth F. Ilett,Neil R. Kitteringham,Michel Eichelbaum,Helen Powell,Randolph M. Spargo,Peter N. Le Souëf,Arthur W. Musk,Rodney F. Minchin	49
9	Elucidation of the genetic basis of the common ‘intermediate metabolizer’ phenotype for drug oxidation by CYP2D6 2000 ·Pharmacogenetics ·Sebastian Raimundo,Joachim E. Fischer,Michel Eichelbaum,Ernst‐Ulrich Griese,Matthias Schwab,Ulrich M. Zanger	149
10	Telomere length in different tissues of elderly patients 2000 ·Mechanisms of Ageing and Development ·Ulrike Friedrich,Ernst‐Ulrich Griese,Matthias Schwab,Péter Fritz,Klaus‐Peter Thon,Ulrich Klotz	264
11	Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing 1999 ·British Journal of Clinical Pharmacology ·Susanne Ammon,Ute Hofmann,Ernst‐Ulrich Griese,(unknown),Gerd Mikus	14
12	Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population 1998 ·Pharmacogenetics ·Ernst‐Ulrich Griese,Ulrich M. Zanger,(unknown),Andrea Gaedigk,Gerd Mikus,(unknown),(unknown),Michel Eichelbaum	223
13	Propafenone in a usual dose produces severe side‐effects: the impact of genetically determined metabolic status on drug therapy 1995 ·Journal of Internal Medicine ·Klaus Mörike,(unknown),Thomas Mettang,Ernst‐Ulrich Griese,Christoph Machleidt,U. Kuhlmann	20
14	Dihydrocodeine: A new opioid substrate for the polymorphic CYP2D6 in humans* 1995 ·Clinical Pharmacology & Therapeutics ·Martin F. Fromm,Ute Hofmann,Ernst‐Ulrich Griese,Gerd Mikus	48
15	Competitive nested polymerase chain reaction for quantification of humanMDR1 gene expression 1994 ·Journal of Cancer Research and Clinical Oncology ·(unknown),Ernst‐Ulrich Griese,Kurt R. Schumacher	4
16	The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes 1994 ·Pharmacogenetics ·Karl Walter Bock,Dieter Schrenk,(unknown),Ernst‐Ulrich Griese,(unknown),D. Brockmeier,Michel Eichelbaum	170
17	Cloning and sequencing of a new non-functional CYP2D6 allele: Deletion of T1795 in exon 3 generates a premature stop codon 1994 ·Pharmacogenetics ·Bernd O. Evert,Ernst‐Ulrich Griese,Michel Eichelbaum	41
18	A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine 1994 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Bernd O. Evert,Ernst‐Ulrich Griese,Michel Eichelbaum	52
19	Inactivation of human alpha-globin gene expression by a de novo deletion located upstream of the alpha-globin gene cluster. 1990 ·Proceedings of the National Academy of Sciences ·Stephen A. Liebhaber,Ernst‐Ulrich Griese,Ingrid M. Weiss,F E Cash,Helena Ayyub,Douglas R. Higgs,J. Horst	46
20	?-Globin gene deletion causes ?-thalassemia syndromes in two German families 1984 ·Human Genetics ·(unknown),Ernst‐Ulrich Griese,E. Kleihauer,E. Kohne	2

About Ernst‐Ulrich Griese

Ernst‐Ulrich Griese is a scholar working on Pharmacology, Genetics and Toxicology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (4 papers) and Telomeres, Telomerase, and Senescence (4 papers). The work is most often cited by research in Pharmacology (895 citations), Aging (73 citations) and Oncology (472 citations). Ernst‐Ulrich Griese has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Michel Eichelbaum, Matthias Schwab, Ulrich Klotz, Ulrike Friedrich, Péter Fritz, Ulrich M. Zanger, Gerd Mikus, Klaus‐Peter Thon, Martin F. Fromm and Bernd O. Evert. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact